Study guide

40.1 Rheumatology and Dermatology: Approach to Arthritis, Osteoarthritis, Rheumatoid Arthritis, Gout, Spondyloarthritis, SLE and Other Connective Tissue Diseases, Vasculitis and Myalgias, Bone Tumors, Common Skin Lesions, Skin Infections and Infestations, Eczema, Psoriasis, Severe Drug Eruptions and Skin Signs of Systemic Disease

Philippine Physician Licensure Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: PLE Structure, Eligibility & Study Strategy

1.1 PLE Format, 2026 Schedule & the Statutory Passing Rule 1.2 Eligibility, Internship, PRC Filing & Test-Day Rules 1.3 Reading the 2025 Tables of Specifications & Building a Study Plan

2 Chapter 2: Physiology I: Cells, Blood, Nerve & Muscle

2.1 Homeostasis, Cell Function, Membrane Transport & Resting Potential 2.2 Blood Cells, Immunity, Hemostasis, Fibrinolysis & Blood Distribution 2.3 Action Potentials, Conduction, the Neuromuscular Junction & Muscle Contraction

3 Chapter 3: Physiology II: Cardiovascular & Respiratory Systems

3.1 Cardiac Electrophysiology, the Cardiac Cycle & the Heart as a Pump 3.2 Circulation: Resistance, Venous Return, Coronary Flow, Microcirculation & Fetal Circulation 3.3 Respiratory Mechanics, Gas Exchange, Gas Transport, Control of Breathing & Extreme Environments

4 Chapter 4: Physiology III: Gastrointestinal, Endocrine, Renal & Reproductive Systems

4.1 Gastrointestinal Physiology: Secretion, Motility, Digestion & Absorption 4.2 Endocrine Physiology: Hormone Chemistry, Axes, Calcium & Fuel Regulation 4.3 Renal Physiology, Body Fluid Balance & Acid-Base Regulation 4.4 Reproductive Physiology: Sexual Differentiation, Spermatogenesis, the Menstrual Cycle, Parturition & Lactation

5 Chapter 5: Physiology IV: Neurophysiology & Special Senses

5.1 Sensory Receptors, Somatic Sensation, Spinal Reflexes & Motor Control 5.2 Higher Brain Functions, Sleep, the Autonomic Nervous System, Cerebral Blood Flow & the Special Senses

6 Chapter 6: Legal Medicine I: Medicolegal Examination, Identification & Death

6.1 The Medicolegal Examination, Physical Evidence & the Crime Scene 6.2 Identification of the Living, the Dead & Skeletal Remains 6.3 Thanatology: Death, Brain Death, Postmortem Changes & Time of Death

7 Chapter 7: Legal Medicine II: Injuries, Sexual Crimes, Reproduction, Mental State & Poisoning

7.1 Physical Injuries: Revised Penal Code Classes, Wounds, Gunshot Injuries, Asphyxia & Burns 7.2 Sexual Crimes, Violence Against Women & Child Abuse 7.3 Medicolegal Aspects of Pregnancy, Delivery, Abortion, Infanticide, Paternity & Marriage 7.4 Disturbance of Mentality: Insanity, Intoxication, Capacity & the Mental Health Act 7.5 Forensic Toxicology & Poisoning: Diagnosis, Evidence, Antidotes & Philippine Laws

8 Chapter 8: Legal Medicine III: Reports, Regulation, Liability & Ethics

8.1 The Medicolegal Report, the Death Certificate, Autopsy Rules & Communicating with Relatives 8.2 Licensure & Regulation of Medical Practice: RA 2382, the Board of Medicine, PRC & Prescribing Laws 8.3 Medical Malpractice: Civil, Criminal & Administrative Liability and Key Philippine Doctrines 8.4 Physician Relationships Under the PMA Code of Ethics: Patients, Colleagues, Allied Health, Students, Industry, HMOs, Hospitals & PhilHealth 8.5 Bioethical Principles, Informed Consent, Confidentiality, End-of-Life & Research Ethics

9 Chapter 9: Pathology I: Cell Injury, Inflammation & Hemodynamics

9.1 Cell Injury, Adaptation, Necrosis, Apoptosis, Accumulations & Calcification 9.2 Acute & Chronic Inflammation, Granulomas, Systemic Effects & Tissue Repair 9.3 Hemodynamic Disorders: Edema, Hemorrhage, Thrombosis, Embolism, Infarction, DIC & Shock

10 Chapter 10: Pathology II: Genetics, Neoplasia, Immunity, Environment & Infection

10.1 Genetic Disorders & Neoplasia: Mendelian, Chromosomal, Non-Classic Inheritance, Tumor Biology & Markers 10.2 Immunopathology: Hypersensitivity, Autoimmunity, Immunodeficiency & Transplant Rejection 10.3 Environmental & Nutritional Pathology: Air Pollution, Tobacco, Metals, Occupational Lung Disease & Deficiency States 10.4 Pathology of Infectious Diseases: Transmission, Tissue Reaction Patterns & Diagnostic Morphology

11 Chapter 11: Pathology III: Gastrointestinal, Cardiovascular & Respiratory Pathology

11.1 Gastrointestinal, Hepatic, Biliary & Pancreatic Pathology 11.2 Cardiovascular & Collagen Pathology: Heart Failure, Congenital, Ischemic, Hypertensive, Valvular, Pericardial & Myocardial Disease 11.3 Respiratory Pathology: Atelectasis, Edema, ARDS, Obstructive & Restrictive Disease, Vascular Disease, Infections, Tumors & Pleura

12 Chapter 12: Pathology IV: Hematopoietic, Genitourinary, Endocrine & Nervous System Pathology

12.1 Hematopoietic Pathology: Anemias, Polycythemia, Bleeding Disorders, DIC & Lymphoid and Myeloid Neoplasms 12.2 Genitourinary Pathology: Glomerular, Tubulointerstitial, Vascular & Cystic Kidney Disease, Renal Tumors, Obstruction & Genital Disorders 12.3 Endocrine Pathology: Pancreas, Adrenal, Parathyroid, Thyroid & Pituitary Disorders 12.4 Nervous System Pathology: Cerebrovascular Disease, Edema & Herniation, Infections, Degenerative & Demyelinating Disease, Tumors

13 Chapter 13: Biochemistry I: Carbohydrate, Protein, Genetic & Energy Biochemistry

13.1 Carbohydrate Chemistry, Digestion, Glycolysis, Pyruvate Dehydrogenase & the Pentose Phosphate Pathway 13.2 Gluconeogenesis, Glycogen, Lipogenesis, Ketogenesis & Hormonal Control of Fuel Metabolism 13.3 Protein Digestion, Amino Acid Catabolism, the Urea Cycle, Heme Synthesis, Porphyrias & Bilirubin Metabolism 13.4 Amino Acids & Proteins: Structure, Properties, Separation, Specialized Products, Collagen & Protein Misfolding in Alzheimer Disease 13.5 Molecular Genetics & Enzymes: Replication, Repair, Gene Expression, Molecular Techniques, Lysosomal Storage Diseases & Enzyme Kinetics 13.6 Bioenergetics, the Citric Acid Cycle, Oxidative Phosphorylation, Muscle Energetics & Nucleotide Metabolism

14 Chapter 14: Biochemistry II: Respiratory, Nutritional, Immunologic & Cardiovascular Biochemistry

14.1 Respiratory Biochemistry: Hemoglobin, Oxygen Binding, Hemoglobinopathies, Thalassemias, Methemoglobin, Buffers & Acid-Base Balance 14.2 Nutrition Biochemistry: Dietary Standards (RENI to PDRI 2015), Food Guides, Protein Quality, Energy Expenditure, Breast Milk, Vitamins, Minerals & Blood Components 14.3 Immunology: Innate & Adaptive Immunity, the Immune Response, Antibodies, Complement, Cytokines & MHC 14.4 Cardiovascular Biochemistry: Cholesterol, Lipoproteins, Dyslipidemias, Atherogenesis, Myocardial Energetics, Biomarkers & Heart Failure

15 Chapter 15: Anatomy I: Thorax, Abdomen, Pelvis & Back

15.1 Thorax: Thoracic Wall, Breast, Pleura & Lungs, Mediastinum, Heart & Great Vessels 15.2 Abdomen: Abdominal Wall & Inguinal Region, Peritoneum, Viscera, Diaphragm & Posterior Abdominal Wall 15.3 Pelvis & Perineum: Bony Pelvis, Pelvic Floor, Pelvic Viscera, Vessels & Nerves, Perineal Pouches & the Anal Canal 15.4 Back & Spinal Column: Vertebrae, Curvatures, Joints, Back Muscles, Spinal Cord, Meninges & Cord Syndromes

16 Chapter 16: Anatomy II: Upper Limb, Lower Limb & Skin

16.1 Upper Limb: Bones, Superficial Veins, Shoulder Muscles, Axilla & Brachial Plexus, Arm, Cubital Fossa, Forearm, Hand & Joints 16.2 Lower Limb: Bones, Venous & Lymphatic Drainage, Thigh, Gluteal Region, Popliteal Fossa, Leg Compartments, Foot, Joints & Gait 16.3 Skin & Appendages: Epidermis, Junctions, Dermis, Subcutaneous Tissue, Fascia, Nerves, Vessels, Lymphatics, Hair, Nails & Glands

17 Chapter 17: Anatomy III: Head, Neck & Histology

17.1 Head I: Skull & Cranial Foramina, Scalp, Face & Parotid, Orbit, Temporal & Infratemporal Fossae, TMJ, Oral Region, Nose & Ear 17.2 Head II: Meninges & Dural Venous Sinuses, Brain Regions & Ventricles, Blood Supply, Cranial Nerves, Pituitary & Pineal, Brainstem Syndromes 17.3 Neck: Cervical Vertebrae & Hyoid, Fascial Layers, Superficial Muscles, Triangles, Root of the Neck, Visceral Layers & Lymphatics 17.4 Histology: Cells, Epithelium & Glands, Connective Tissue & Fat, Cartilage & Bone, Blood & Hematopoiesis, Muscle, Nerve, Vessels, Lymphoid Organs & Organ Histology

18 Chapter 18: Microbiology I: Foundations, Respiratory & Cardiovascular Infections

18.1 Microbiology Foundations: The Organ-System TOS, Specimens & Stains, Gram-Positive and Gram-Negative Bacteria 18.2 Respiratory Infections: Tonsillitis, Sinusitis & Mastoiditis, Bronchitis, Community-Acquired & Severe Pneumonia, Bronchiectasis and Paragonimiasis 18.3 Tuberculosis, Leprosy & Nontuberculous Mycobacteria: Pathogenesis, Diagnosis, NTP Regimens & Prevention 18.4 Cardiovascular Infections: Infective Endocarditis, Rheumatic Fever & Rheumatic Heart Disease, Myocarditis, Pericarditis and Septic Thrombophlebitis

19 Chapter 19: Microbiology II: Gastrointestinal & Nervous System Infections

19.1 Gastrointestinal Infections I: Gastroenteritis & Enterocolitis, Cholera, Typhoid & Salmonellosis, Shigellosis, Food Poisoning and Viral Hepatitis 19.2 Gastrointestinal Infections II: Amebiasis, Giardiasis & Cryptosporidiosis, Soil-Transmitted Helminths, Pinworm, Capillariasis and Tapeworms 19.3 Nervous System Infections: Meningitis & CSF Patterns, Encephalitis, Rabies and DOH PEP, Spinal Cord Infections, Tetanus & Botulism, Paralytic Shellfish Poisoning

20 Chapter 20: Microbiology III: Genitourinary, Reproductive, Blood & Skin Infections

20.1 Genitourinary Infections: Cystitis & Pyelonephritis, Urine Diagnostics, Urethritis, Balanoposthitis, Pelvic Inflammatory Disease and Genital Ulcers 20.2 Reproductive Tract Infections & STIs: Syphilis, Genital & Neonatal Herpes, HPV, Molluscum, CMV, Trichomoniasis & Vaginitis, Cervicitis, Prostatitis and Orchitis 20.3 Hematopoietic & Lymphatic Infections: Dengue and Other Hemorrhagic Fevers, Malaria, Lymphatic Filariasis, Lymphogranuloma Venereum and Epstein-Barr Virus 20.4 Integumentary Infections: Viral Exanthems (Measles, Mumps, Rubella, Varicella, Smallpox & Mpox, Fifth Disease), Herpesviruses, Fungal Skin Infections and Tick-Borne Diseases

21 Chapter 21: Microbiology IV: Musculoskeletal & Multisystemic Infections

21.1 Musculoskeletal & Soft-Tissue Infections: Osteomyelitis, Septic & Reactive Arthritis, Pyomyositis & Gas Gangrene, Cellulitis, Necrotizing Fasciitis and Bite Wounds 21.2 Multisystemic Infections I: Septicemia, Septicopyemia & Septic Shock, Leptospirosis and Schistosomiasis japonica 21.3 Multisystemic Infections II: HIV/AIDS Virology, the Philippine Epidemic & RA 11166, Diagnosis (rHIVda), ART, Prevention and Opportunistic Infections including Toxoplasmosis

22 Chapter 22: Obstetrics I: Prenatal Care, Labor & Obstetric Bleeding

22.1 Prenatal Care: Diagnosis of Pregnancy, Maternal Physiology, Dating, Nutrition & Supplements, Screening Tests and the DOH Antenatal Package 22.2 Labor & Parturition: Signs of Labor, Pelvis and Passenger, Stages and Cardinal Movements, Partograph, Fetal Monitoring, Dystocia, Shoulder Dystocia, Operative Delivery, Preterm Labor, PROM and Adolescent Pregnancy 22.3 Early Pregnancy Risks & Bleeding: Hyperemesis, Spontaneous Abortion, Recurrent Loss & Cervical Insufficiency, Ectopic Pregnancy, Hydatidiform Mole & Gestational Trophoblastic Neoplasia 22.4 Hemorrhagic Complications of Pregnancy: Placenta Previa, Abruption, Vasa Previa, Placenta Accreta Spectrum, Uterine Rupture, Third-Stage Management and Postpartum Hemorrhage

23 Chapter 23: Obstetrics II: Fetal, Hypertensive, Medical, Infectious & Postpartum Problems

23.1 Fetal Complications: Malpresentation & Breech, Macrosomia, Fetal Growth Restriction, Amniotic Fluid Disorders, Antepartum Surveillance, Rh Alloimmunization, Multiple Gestation and Post-Term Pregnancy 23.2 Hypertension & Diabetes in Pregnancy: Classification, Preeclampsia Pathogenesis and Prevention, Severe Features, Eclampsia & HELLP, Magnesium Sulfate, Gestational and Pregestational Diabetes 23.3 Medical & Surgical Disorders in Pregnancy: Drug Pharmacokinetics, Epilepsy, Thyroid, Heart Disease, SLE & APS, Asthma, Liver Disorders, Anemia, Dermatoses, Appendicitis, Gallstones, Stones and Trauma 23.4 Perinatal Infections: Triple Elimination (HIV, Syphilis, Hepatitis B), Group B Streptococcus, Chorioamnionitis, Gonorrhea & Chlamydia, Condyloma, Herpes and the TORCH Infections 23.5 Postpartum Care & Complications: Normal Puerperium, Postnatal Visits, Breastfeeding, Puerperal Fever and Infection, Mastitis, Late Hemorrhage, Mood Disorders, VTE and Postpartum Contraception

24 Chapter 24: Gynecology I: Benign Disorders, Infections & Contraception

24.1 Benign Lower Genital Tract Disorders & Pelvic Floor: Vulvar Dermatoses, Bartholin Cysts, Vaginal and Cervical Lesions, Premalignant Lesions, Pelvic Organ Prolapse, Urinary Incontinence and Fistula 24.2 Benign Upper Genital Tract Disorders: Leiomyoma, Adenomyosis & Endometriosis, Endometrial Polyps and Hyperplasia, Functional Cysts and Benign Ovarian Tumors, Adnexal Torsion and Tubal Disease 24.3 Infections of the Female Reproductive Tract: Burden & Screening, Syndromic Management, Vaginitis and Cervicitis, Pelvic Inflammatory Disease & Tubo-Ovarian Abscess, Genital Tuberculosis and Toxic Shock 24.4 Contraception & Family Planning: The RH Law, Effectiveness, Natural and Barrier Methods, Hormonal Methods, IUDs, Permanent Methods, Emergency Contraception and the WHO Eligibility Criteria

25 Chapter 25: Gynecology II: Reproductive Endocrinology, Oncology & Special Issues

25.1 Reproductive Endocrinology & Menstrual Disorders: The Menstrual Cycle, Puberty, Abnormal Uterine Bleeding (PALM-COEIN), Amenorrhea, PCOS, Hyperprolactinemia, Dysmenorrhea, Infertility, Menopause, HRT and Osteoporosis 25.2 Gynecologic Oncology: Cervical Cancer Screening, Staging & Treatment, Endometrial Cancer and Lynch Syndrome, Ovarian Tumors and BRCA, Vulvar and Vaginal Cancer, Survival and Quality of Life 25.3 Contemporary Issues & Pediatric and Adolescent Gynecology: Violence Against Women, Sexual Assault Care, Breast Disorders, Ethics of Maternal-Fetal Conflict, and Gynecologic Problems of Children and Adolescents

26 Chapter 26: Pediatrics I: Newborn, Growth, Nutrition, Immunization & Infections

26.1 The Newborn: Normal Findings and Variants, EINC (Unang Yakap), APGAR, Neonatal Resuscitation, Routine Care & Newborn Screening, Jaundice, Respiratory Distress, Hypoglycemia and Neonatal Sepsis 26.2 Growth, Development & Nutrition: Growth Parameters, Milestones and Red Flags, Speech Delay, Autism, ADHD & Global Delay, Breastfeeding and Feeding, Micronutrient Deficiencies, Malnutrition and Obesity 26.3 Immunization: RA 10152 and the National Immunization Program Schedule, Fully Immunized Child, School-Based Immunization, Other Recommended Vaccines, Vaccine Types, Cold Chain, Contraindications and AEFI 26.4 Pediatric Infectious Diseases: Bacterial (Diphtheria to Congenital Syphilis), Childhood TB, Viral Exanthems and Infections, Dengue in Children, Pediatric HIV, Protozoal, Helminthic and Fungal Infections

27 Chapter 27: Pediatrics II: Respiratory, Cardiovascular, Neurologic & Gastrointestinal Disorders

27.1 Pediatric Respiratory Disorders: IMCI Danger Signs and Cough Assessment, URI, Tonsillitis & Peritonsillar Abscess, Croup, Epiglottitis, Foreign Body, Bronchiolitis, Pneumonia, Pleural Effusion and Complications 27.2 Pediatric Cardiovascular & Collagen Disorders: Heart Sounds and Murmurs, Acyanotic and Cyanotic Congenital Heart Disease, Eisenmenger, Hypercyanotic Spells, Heart Failure, Rheumatic Fever, Hypertension, Endocarditis, Kawasaki, SLE, JIA, Dermatomyositis and Pediatric Resuscitation 27.3 Pediatric CNS Disorders: Febrile Seizures, Epilepsy Syndromes, Status Epilepticus, Meningitis and Encephalitis in Children, Cerebral Palsy, Hydrocephalus & Neural Tube Defects, Headache and Migraine, and Brain Tumors 27.4 Pediatric GI Disorders & Poisoning: Vomiting (Pyloric Stenosis, Atresias, Malrotation, Intussusception, GERD), Diarrhea and IMCI Rehydration Plans, Abdominal Pain, Constipation & Hirschsprung, Jaundice, Biliary Atresia & Choledochal Cyst, Hepatitis, Food Allergy, and Kerosene, Aspirin and INH Poisoning

28 Chapter 28: Pediatrics III: Genitourinary, Endocrine, Hematologic & Oncologic Disorders

28.1 Pediatric Genitourinary Disorders & Child Abuse: UTI and Vesicoureteral Reflux, Post-Streptococcal GN and Other Nephritides, Nephrotic Syndrome, AKI and HUS, CKD, Congenital Urogenital Anomalies, and Recognizing and Reporting Child Abuse 28.2 Pediatric Endocrine & Metabolic Disorders: Short Stature and Growth Hormone, Gigantism, Diabetes Insipidus, Congenital Hypothyroidism, Graves Disease & Goiter, Type 1 Diabetes and DKA, Congenital Adrenal Hyperplasia, Cushing Syndrome, Pheochromocytoma and Adrenal Crisis 28.3 Pediatric Hematology, Allergy & Immunology: Normal Hemogram and Immunoglobulins by Age, Anemias (Iron Deficiency, Thalassemia, G6PD, Spherocytosis, Aplastic), Bleeding Disorders (ITP, Hemophilia, vWD, DIC, Vitamin K), IgA Vasculitis, Rashes and Drug Reactions, Asthma, Allergic Rhinitis and Primary Immunodeficiencies 28.4 Pediatric Oncology & Genetics: Leukemias and Lymphomas, Retinoblastoma, Wilms Tumor, Neuroblastoma, Ewing Sarcoma and Osteosarcoma; Sex Chromosome and Autosomal Disorders, Inborn Errors of Metabolism and the Dysmorphic ("Odd-Looking") Child

29 Chapter 29: Preventive Medicine I: The Physician as Health Care Provider

29.1 The Physician as Health Care Provider I: Natural History of Disease, Disease Causation, Levels of Prevention and Primary Care Across the Clinical Rotations 29.2 The Physician as Health Care Provider II: The Filipino Family and Family Assessment Tools, Health Education and Promotion, Behavior Change Models and Geriatric Medicine 29.3 The Physician as Health Care Provider III: The Primary Health Care Concept (Alma-Ata, Astana, Philippine PHC) and Mental Health in Primary Care under RA 11036

30 Chapter 30: Preventive Medicine II: Philippine Health Care System & Community Medicine

30.1 The Philippine Health Care System: DOH Structure, Levels of Care and Referral, Devolution under RA 7160, the Universal Health Care Act (RA 11223), PhilHealth and YAKAP, and Leading Causes of Morbidity and Mortality 30.2 Epidemiology, Surveillance & Outbreaks: Measures of Disease Occurrence and Association, Rates, Endemic and Epidemic Levels, PIDSR and RA 11332 Notifiable Diseases, the Ten Steps of Outbreak Investigation and Epidemic Curves 30.3 DOH Programs & Environmental Sanitation: TB, Dengue, Rabies, Leprosy, Helminth and Other Disease Programs; the Sanitation Code (PD 856), Water Supply and Potability, Excreta and Solid Waste, Food Sanitation and Health Care Waste 30.4 Community Medicine: Principles of Public Health Administration and Program Planning, Vital Health Indices (Infant and Maternal Mortality), the Ecologic Concept of Health, Lifestyle and Non-Communicable Diseases, Health-Seeking Behavior and Traditional Medicine

31 Chapter 31: Preventive Medicine III: Manager, Researcher & Social Mobilizer

31.1 The Physician as Administrative Manager: Communication and Interpersonal Skills, Teamwork, Adult Learning, Occupational Health (RA 11058), Bioethics, Palliative Care, School Health, Organ Transplantation and Birth and Death Certificates 31.2 The Physician as Researcher I: The Research Process and Proposal, Research Ethics, Study Designs and Meta-Analysis, Demography and Vital Statistics, Evidence-Based Medicine and Quality Assurance 31.3 The Physician as Researcher II: Biostatistics (Data Types, Distributions, Central Tendency and Dispersion, Confidence Intervals, Hypothesis Testing and Test Selection) and Screening Tests (Validity, Predictive Values, Likelihood Ratios, Biases and Program Criteria) 31.4 The Physician as Social Mobilizer and Leader: Philippine Health Laws, Decrees and Executive Orders, Principles of Social Mobilization and Community Organizing, and Disaster Risk Reduction and Management in Health

32 Chapter 32: Pharmacology I: Principles, Cardiovascular & Nervous System Therapeutics

32.1 Pharmacology Foundations: The Pharmacology TOS, Pharmacokinetics, Drug Metabolism and Interactions, Pharmacodynamics, Adverse Drug Reactions and Monitoring, Autonomic Pharmacology, and Philippine Prescribing Rules 32.2 Cardiovascular Pharmacology I: Cardiac Arrest and ACLS Drugs, Bradycardia and Complete Heart Block, Antiarrhythmics, Anticoagulation in Atrial Fibrillation, Antianginals, ACS Therapy and Fibrinolysis, Pericarditis and Endocarditis Regimens 32.3 Cardiovascular Pharmacology II: Antihypertensives and Diuretics, Hypertensive Emergencies, Vasopressors and Inotropes in Shock, Heart Failure GDMT and Digoxin, and Lipid-Lowering Therapy 32.4 Nervous System Pharmacology I: Antiseizure Drugs and Status Epilepticus, Headache and Migraine, Vertigo, Stroke Thrombolysis and Secondary Prevention, Encephalopathy, Dementia, ADHD, Parkinson Disease and Movement Disorders, Raised Intracranial Pressure and CNS Infections

33 Chapter 33: Pharmacology II: Psychiatric, Respiratory & Genitourinary Therapeutics

33.1 Nervous System Pharmacology II: Antidepressants and Their Toxicity, Serotonin Syndrome, Anxiolytics and Hypnotics, Antipsychotics, EPS and NMS, Lithium and Mood Stabilizers, Sleep Disorders, Agitation and Alcohol Withdrawal 33.2 Respiratory Pharmacology: Cough and Colds, Allergic Rhinitis, Asthma (Controllers, Relievers, Exacerbations), COPD, Anti-TB Drugs, Antibiotics for Pneumonia and Bronchitis, and Lung Cancer Therapy 33.3 Genitourinary Pharmacology I: Antimicrobial Classes and Toxicities, and Drug Treatment of UTI, Pyelonephritis, Gonorrhea, Chlamydia, Syphilis, Genital Herpes, Genital Warts, PID, Vaginitis, Prostatitis and Orchitis 33.4 Genitourinary Pharmacology II: Kidney Stones, Nephrotic and Nephritic Disease, Drug Dosing in Kidney Disease and Hyperkalemia, Benign Prostatic Hyperplasia, Erectile Dysfunction, Renal Cell Carcinoma and Prostate Cancer Therapy

34 Chapter 34: Pharmacology III: Digestive, Endocrine, Skin & Musculoskeletal Therapeutics

34.1 Digestive Pharmacology: Portal Hypertension and Variceal Bleeding, Acid-Peptic Disease, H. pylori and GERD, Antiemetics, Laxatives and Antidiarrheals, Biliary and Pancreatic Disease, GI Infections and Parasites, Viral Hepatitis, C. difficile, Candidiasis and GI Cancer Chemotherapy 34.2 Endocrine Pharmacology I: Diabetes Mellitus Drugs (Metformin, Sulfonylureas, SGLT2 Inhibitors, GLP-1 Agonists, DPP-4 Inhibitors, Thiazolidinediones, Insulins), Choosing Therapy by Comorbidity, DKA and HHS, and Hypoglycemia 34.3 Endocrine Pharmacology II: Pituitary Disorders (GH Deficiency, Acromegaly, Prolactinoma, Diabetes Insipidus, Panhypopituitarism), Thyroid Drugs and Thyroid Storm, Calcium and Parathyroid Disorders, Adrenal Disorders and Corticosteroids 34.4 Cutaneous and Musculoskeletal Pharmacology: Cellulitis and Abscess, Drug-Induced Skin Reactions (SJS/TEN), Pain Management (Paracetamol, NSAIDs, Opioids), Osteoporosis, Rheumatoid Arthritis and Osteoarthritis, Septic and TB Arthritis, Gout, SLE and Psoriasis

35 Chapter 35: Surgery I: Basic Surgical Principles

35.1 Basic Surgical Principles I: The Surgery TOS, Fluids and Electrolytes, Acid-Base Balance, the Metabolic Response to Injury, Surgical Nutrition and Blood Transfusion 35.2 Basic Surgical Principles II: Shock and Surgical Critical Care, Hemorrhagic Shock and Massive Transfusion, ATLS Primary and Secondary Survey, Chest and Abdominal Trauma, Head and Spine Injury, Pelvic Fractures and Burns 35.3 Basic Surgical Principles III: Preoperative Assessment, Wound Healing, Surgical Infection and Asepsis, Postoperative Fever, Surgical Oncology, Immunology and Transplantation, Anesthesia and Patient Safety

36 Chapter 36: Surgery II: Abdomen, Breast & Hernia

36.1 Abdomen I: Esophagus (Hiatal Hernia, GERD, Achalasia, Caustic Injury, Barrett, Boerhaave, Mallory-Weiss, Cancer), Stomach and Duodenum (Peptic Ulcer Complications, Upper GI Bleeding, Gastric Cancer, GIST), Small Bowel (Obstruction, Ileus, Tumors, Typhoid and TB), Retroperitoneum and Abdominal Wall 36.2 Abdomen II: Gallstones, Cholecystitis, Choledocholithiasis and Cholangitis, Obstructive Jaundice, Liver (Cirrhosis, Portal Hypertension, Abscesses, Tumors and Hepatocellular Carcinoma), Pancreas (Acute and Chronic Pancreatitis, Pancreatic Cancer) and Spleen (Splenectomy, OPSI) 36.3 Abdomen III: Acute Appendicitis, Colonic Obstruction and Volvulus, Lower GI Bleeding, Diverticular Disease, Colorectal Polyps and Cancer, Hemorrhoids, Anal Fissure, Perianal Abscess and Fistula 36.4 Breast, Hernia and Skin and Soft Tissue: Benign Breast Masses, Breast Cancer Evaluation and Treatment, Groin and Abdominal Wall Hernias, Benign Skin and Soft-Tissue Tumors, Skin Cancers and Soft-Tissue Sarcoma

37 Chapter 37: Surgery III: Surgical Specialties

37.1 Head and Neck, Thyroid, Parathyroid, Endocrine and Bariatric Surgery and Otorhinolaryngology: Neck Masses and Head and Neck Cancer, Salivary Glands, Thyroid Nodules and Cancer, Goiter and Hyperthyroidism Surgery, Hyperparathyroidism, Adrenal Surgery, Bariatric Surgery, Nasal Polyps, Epistaxis, Vertigo, Hearing Loss and ENT Infections 37.2 Specialty I: Neurosurgery (Raised Intracranial Pressure and Herniation, Head Injury and Hematomas, Spontaneous Intracranial Hemorrhage, CNS and Peripheral Nerve Tumors, Spinal Cord Compression, Neurosurgical Infections) and Ophthalmology (Glaucoma, Cataract, Ophthalmic Emergencies) 37.3 Specialty II: Thoracic and Cardiovascular Surgery (Pleural Effusion and Empyema, Lung Cancer, Mediastinal Masses, Surgical Heart Disease, Aortic Aneurysm and Dissection, Peripheral Arterial and Venous Disease), Urology (Stones, Infections, Torsion, BPH, Urologic Tumors) and Gynecologic Surgery 37.4 Specialty III: Plastic and Reconstructive Surgery (Skin Grafts and Flaps, Cleft Lip and Palate, Facial Fractures, Hand Injuries), Orthopedics (Fractures, Dislocations, Bone and Joint Infections, Bone Tumors) and Pediatric Surgery (Hernias, CDH, Esophageal Atresia, Obstruction, Hirschsprung Disease, Neonatal Jaundice, Tumors)

38 Chapter 38: Medicine I: Cardiovascular, Digestive & Endocrine Medicine

38.1 Cardiovascular Medicine I: Hypertension and Secondary Causes, Dyslipidemia, Stable Angina and Acute Coronary Syndromes, Post-MI Complications, Heart Failure and Shock Syndromes 38.2 Cardiovascular Medicine II: Tachyarrhythmias and Bradyarrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Brugada Syndrome, Cardiac Arrest, Valvular and Rheumatic Heart Disease, Infective Endocarditis, Myocarditis and Pericardial Disease 38.3 Gastroenterology and Hepatology: GERD and Peptic Ulcer Disease, Upper and Lower GI Bleeding, Diarrhea and GI Infections, Acute Pancreatitis and Biliary Disease, Viral Hepatitis, Cirrhosis and Portal Hypertension, Liver and GI Cancers 38.4 Endocrinology: Diabetes Mellitus Diagnosis, Treatment and Complications, DKA and HHS, Thyroid Disease, Pituitary Disorders, Adrenal Disorders (Cushing, Aldosteronism, Addison, Pheochromocytoma), Calcium and Parathyroid Disorders, Obesity and Metabolic Syndrome

39 Chapter 39: Medicine II: Hematology, Systemic Infections, Renal & Respiratory Medicine

39.1 Hematology, Immunology and Systemic Infections: Anemias (Iron Deficiency, Thalassemia, G6PD Deficiency, Megaloblastic, Hemolytic), Acute and Chronic Leukemias and Their Emergencies, Allergic Disorders, Dengue in Adults, COVID-19, Malaria and HIV/AIDS Opportunistic Infections 39.2 Nephrology: Acute Kidney Injury, Chronic Kidney Disease and Dialysis, Sodium and Potassium Disorders, Acid-Base Analysis, Urinary Tract Infections, Glomerular Diseases (Nephritic and Nephrotic), Kidney Stones, Renal Tumors and Sexually Transmitted Infections 39.3 Pulmonology and Critical Care: Acute Respiratory Failure and Oxygen Therapy, Bronchial Asthma, COPD, Community- and Hospital-Acquired Pneumonia, Pulmonary Tuberculosis and TB Infection, Pulmonary Embolism, Lung Cancer and ARDS

40 Chapter 40: Medicine III: Rheumatology, Dermatology, Neurology, Rehabilitation & Psychiatry

40.1 Rheumatology and Dermatology: Approach to Arthritis, Osteoarthritis, Rheumatoid Arthritis, Gout, Spondyloarthritis, SLE and Other Connective Tissue Diseases, Vasculitis and Myalgias, Bone Tumors, Common Skin Lesions, Skin Infections and Infestations, Eczema, Psoriasis, Severe Drug Eruptions and Skin Signs of Systemic Disease 40.2 Neurology and Rehabilitation Medicine: Stroke and TIA (Localization, Thrombolysis, Thrombectomy, Secondary Prevention), Intracranial Hemorrhage, Seizures and Status Epilepticus, Meningitis and Encephalitis, Tetanus and Rabies, Parkinsonism, Neuromuscular and Degenerative Diseases, Dementia, CNS Tumors, Post-Stroke Rehabilitation and Musculoskeletal Disorders 40.3 Psychiatry: Mental Status Examination, Depressive Disorders, Bipolar Disorder, Schizophrenia and Other Psychoses, Anxiety Disorders, OCD and Trauma-Related Disorders, Substance Use, and Acute Psychiatric Emergencies (Suicide Risk, Agitation, Withdrawal, Wernicke Encephalopathy)

40.1 Rheumatology and Dermatology: Approach to Arthritis, Osteoarthritis, Rheumatoid Arthritis, Gout, Spondyloarthritis, SLE and Other Connective Tissue Diseases, Vasculitis and Myalgias, Bone Tumors, Common Skin Lesions, Skin Infections and Infestations, Eczema, Psoriasis, Severe Drug Eruptions and Skin Signs of Systemic Disease

Key Takeaways Explain This Topic AI

Inflammatory arthritis causes morning stiffness over 1 hour that improves with use; osteoarthritis causes pain worse with use, stiffness under 30 minutes and Heberden and Bouchard nodes.

An acutely hot swollen joint must be aspirated to look for crystals and infection; gout shows negatively birefringent needle-shaped crystals.

Inflammatory back pain in a young man (better with exercise, night pain, morning stiffness) with sacroiliitis suggests ankylosing spondylitis (HLA-B27).

Suspected giant cell arteritis (new headache, jaw claudication, visual symptoms, high ESR in someone over 50) needs high-dose steroids immediately, before the biopsy.

Carbamazepine can cause SJS/TEN in carriers of HLA-B*15:02, common in Southeast Asians; any drug causing SJS/TEN must be stopped at once and never restarted.

Last updated: October 2026

Why this area matters

Gout is common in Filipino men (linked to seafood, organ meats, beer and sugary drinks), and SLE in young Filipino women often presents with lupus nephritis . Scabies, tinea and impetigo are among the most common skin problems in crowded homes and schools, and severe drug eruptions in Asians are partly genetic. The PLE asks you to classify joint pain, interpret the joint fluid and autoantibodies, and recognize dangerous rashes.

Approach to joint and muscle pain

Inflammatory or mechanical?

inflammatory : morning stiffness over 1 hour , swelling, warmth, and improvement with activity (RA, spondyloarthritis, crystal arthritis);

mechanical : pain worse with use, stiffness under 30 minutes (osteoarthritis).

Number of joints:

monoarthritis : septic arthritis , gout , pseudogout and trauma. Aspirate the joint for cell count, Gram stain, culture and crystals;

oligoarthritis (2 to 4 joints): spondyloarthritis and reactive arthritis;

polyarthritis : RA, SLE, viral arthritis ( chikungunya , parvovirus, hepatitis B) and psoriatic arthritis.

Osteoarthritis:

degeneration of cartilage in knees , hips, the hands ( DIP joints: Heberden nodes; PIP joints: Bouchard nodes ) and spine;

X-ray shows joint space narrowing, osteophytes, subchondral sclerosis and cysts ;

treated with weight loss, exercise and physiotherapy , topical then oral NSAIDs, intra-articular steroids, and joint replacement for end-stage disease.

Myalgias:

  • viral illness, leptospirosis (calf tenderness), dengue and influenza;
  • statin myopathy (check CK);
  • hypothyroidism ;
  • polymyalgia rheumatica ;
  • inflammatory myopathies ;

fibromyalgia : widespread pain, fatigue and poor sleep with normal tests, treated with exercise, sleep care and duloxetine or amitriptyline.

  • Autoimmune & Rheumatologic Disorders
  • Rheumatoid Arthritis (RA)

Symmetric, destructive inflammatory polyarthritis driven by synovial proliferation (pannus formation), bone erosion, and cartilage degradation.

Clinical Presentation: Pain, warmth, and swelling symmetrically involving small joints of the hands and feet: Metacarpophalangeal (MCP) , Proximal Interphalangeal (PIP) , and wrist joints. Characterized by prolonged morning stiffness lasting > 1 hour > 1\text{ hour} > 1 hour that improves with joint movement. Spares the distal interphalangeal (DIP) joints and thoracolumbar spine (cervical spine atlantoaxial subluxation is a serious exception).

Autoantibody Biomarkers:

Anti-Cyclic Citrullinated Peptide (Anti-CCP / ACPA): Highly specific ( > 95 − 98 % > 95-98\% > 95 − 98% ); predicts progressive, erosive joint destruction.

Rheumatoid Factor (RF): IgM autoantibody against the Fc portion of human IgG. Sensitive ( 70 − 80 % 70-80\% 70 − 80% ) but non-specific (seen in hepatitis C, SBE, SLE, Sjogren's).

Pharmacotherapy: Early initiation of Disease-Modifying Antirheumatic Drugs (DMARDs) is mandatory to prevent irreversible joint deformity. Methotrexate (MTX) is the first-line anchor conventional DMARD (dihydrofolate reductase inhibitor; co-prescribe folic acid 1 − 5 mg/day 1-5\text{ mg/day} 1 − 5 mg/day ; monitor for hepatotoxicity, cytopenias, and pneumonitis; strictly contraindicated in pregnancy). Biologic DMARDs (TNF-alpha inhibitors: Infliximab, Adalimumab, Etanercept) are indicated for refractory disease; screening for latent tuberculosis (IGRA/PPD) and hepatitis B is mandatory before initiation to prevent fulminant reactivation.

Systemic Lupus Erythematosus (SLE)

Multisystem autoimmune disorder mediated by autoantibody production and immune complex deposition (Types II and III hypersensitivity), predominantly affecting young women of childbearing age.

EULAR/ACR 2019 Classification: Entry criterion is an Antinuclear Antibody (ANA) titer ≥ 1 : 80 \ge 1:80 ≥ 1 : 80 . Additive weighted domains include constitutional fever; cutaneous (malar rash, discoid lupus, oral ulcers, non-scarring alopecia); arthritis; serositis (pericarditis, pleuritis); hematologic (autoimmune hemolytic anemia, leukopenia < 4 , 000 / μ L < 4,000/\mu\text{L} < 4 , 000/ μ L , thrombocytopenia < 100 , 000 / μ L < 100,000/\mu\text{L} < 100 , 000/ μ L ); neurologic (seizures, psychosis); and renal (proteinuria > 0.5 g/24h > 0.5\text{ g/24h} > 0.5 g/24h or biopsy-proven lupus nephritis).

Diagnostic Autoantibody Profiles:

Antinuclear Antibody (ANA): Most sensitive ( > 95 % > 95\% > 95% ); ideal screening test; low specificity.

Anti-double-stranded DNA (Anti-dsDNA): Highly specific ( > 95 % > 95\% > 95% ); titers fluctuate with disease activity and correlate strongly with lupus nephritis and complement consumption (low serum C3 and C4).

Anti-Smith (Anti-Sm): Highest specificity for SLE; does not correlate with disease activity.

Anti-Ro/SSA & Anti-La/SSB: Associated with subacute cutaneous lupus, secondary Sjögren syndrome, and neonatal lupus complicated by congenital complete heart block.

Management: Hydroxychloroquine is recommended for all SLE patients (reduces disease flares, organ accrual, and thrombosis; requires baseline and annual retinal screening after 5 years for chloroquine maculopathy). Systemic glucocorticoids for acute disease flares; immunosuppressive therapy (Mycophenolate Mofetil or IV Cyclophosphamide) is standard for proliferative lupus nephritis (Class III/IV).

Crystalline Arthropathies: Gout versus Pseudogout

  • Diagnostic Characteristic Acute Gouty Arthritis Calcium Pyrophosphate Deposition (Pseudogout)
  • Primary Crystal Composition Monosodium Urate (MSU) Calcium Pyrophosphate Dihydrate (CPPD)

Polarized Light Microscopy Needle-shaped crystals exhibiting strong negative birefringence (bright yellow when parallel to compensator axis; blue when perpendicular) Rhomboid- or rod-shaped crystals exhibiting weak positive birefringence (blue when parallel to compensator axis; yellow when perpendicular)

Classic Anatomic Sites First Metatarsophalangeal Joint (Podagra) in > 50 % > 50\% > 50% ; ankles, knees Knee joint ( > 50 % > 50\% > 50% ) , wrists, shoulders

Radiographic Hallmarks Chronic "punched-out" bone erosions with sclerotic, overhanging cortical margins (Martel sign); soft tissue tophi Linear calcification of articular cartilage ( chondrocalcinosis ), meniscus calcification

Acute Flare Management High-dose oral NSAIDs (Indomethacin, Naproxen); oral Colchicine ( 1.2 mg 1.2\text{ mg} 1.2 mg load, then 0.6 mg 0.6\text{ mg} 0.6 mg 1 hour later); oral or intra-articular glucocorticoids Intra-articular or oral glucocorticoids, NSAIDs, colchicine

Chronic Maintenance Therapy Urate-Lowering Therapy (ULT): Allopurinol (xanthine oxidase inhibitor; test for HLA-B*58:01 before starting in patients of Southeast Asian ancestry and African American patients (ACR 2020), to prevent severe allopurinol hypersensitivity (DRESS/SJS)); Febuxostat; target uric acid < 6.0 mg/dL < 6.0\text{ mg/dL} < 6.0 mg/dL No effective crystal-dissolving therapy; low-dose colchicine or NSAIDs for recurrent attacks

More on gout and RA:

Gout triggers: alcohol (especially beer), seafood and red meat, fructose drinks , dehydration, thiazide and loop diuretics , low-dose aspirin and starting urate-lowering therapy.

Indications for urate-lowering therapy: tophi , 2 or more flares a year , radiographic damage, and (conditionally) kidney stones or CKD.

Starting allopurinol:

  • start low (50 to 100 mg a day, lower in CKD) and titrate to a urate target below 6 mg/dL ;
  • give colchicine or an NSAID as flare prophylaxis for 3 to 6 months;

do not stop ULT during a flare.

RA extra-articular features: rheumatoid nodules , interstitial lung disease, scleritis, Felty syndrome (RA, splenomegaly, neutropenia), vasculitis and atlantoaxial subluxation (check before intubation). Risk of coronary disease is increased.

Spondyloarthritis

Ankylosing spondylitis:

  • inflammatory back pain in men under 40: insidious, night pain, morning stiffness that improves with exercise ;
  • sacroiliitis on X-ray or MRI, later a "bamboo spine" ;
  • HLA-B27 , anterior uveitis and enthesitis (Achilles tendon);

treated with NSAIDs and exercise, then TNF or IL-17 inhibitors .

Reactive arthritis: asymmetric oligoarthritis after urethritis (chlamydia) or dysentery ( Shigella , Salmonella , Campylobacter ) , with conjunctivitis and urethritis.

Psoriatic arthritis: DIP involvement, dactylitis ("sausage digits"), nail pitting and arthritis mutilans .

Other connective tissue diseases and vasculitis

Systemic sclerosis:

Raynaud phenomenon , skin thickening ( sclerodactyly ), digital ulcers, GERD and dysmotility, interstitial lung disease and pulmonary hypertension ;

limited form (CREST: calcinosis, Raynaud, esophageal dysmotility, sclerodactyly, telangiectasia) with anti-centromere antibodies;

diffuse form with anti-Scl-70 (topoisomerase) ;

scleroderma renal crisis : sudden severe hypertension and AKI, treated with an ACE inhibitor .

Sjögren syndrome: dry eyes and mouth, parotid swelling, anti-Ro and anti-La , and an increased lymphoma risk.

Inflammatory myopathies:

proximal symmetric weakness with high CK ;

dermatomyositis : heliotrope rash and Gottron papules , with a link to cancer (screen adults, including nasopharyngeal cancer in Southeast Asians);

treated with steroids and immunosuppressants.

Antiphospholipid syndrome: venous or arterial thrombosis or pregnancy loss with lupus anticoagulant, anticardiolipin or anti-beta2 glycoprotein I antibodies on two tests 12 weeks apart. Treated with warfarin (DOACs are less effective in high-risk patients).

Polymyalgia rheumatica: people over 50 with shoulder and hip girdle aching and stiffness and a high ESR. Responds dramatically to low-dose prednisone .

Giant cell arteritis:

people over 50 with a new headache , scalp tenderness , jaw claudication , visual loss and a high ESR;

give high-dose steroids immediately to prevent blindness, then confirm with temporal artery biopsy or ultrasound.

Other vasculitides:

  • Takayasu arteritis (young Asian women, absent arm pulses);
  • Kawasaki disease (children);
  • polyarteritis nodosa (hepatitis B);

ANCA vasculitis (granulomatosis with polyangiitis: sinuses, lungs and kidneys).

Bone tumors and metabolic bone disease in adults

Metastases are the most common bone tumors: lytic (lung, kidney, thyroid, myeloma) or blastic ( prostate ).

Multiple myeloma:

older adults with CRAB features : hyperCalcemia, Renal failure, Anemia and lytic Bone lesions;

rouleaux , an M spike on serum protein electrophoresis, free light chains (Bence Jones protein) and more than 10% clonal plasma cells in the marrow;

bone scans miss lytic lesions , so use skeletal survey or whole-body low-dose CT.

Paget disease of bone: high ALP, bone pain, enlarged skull and deafness, treated with bisphosphonates.

Osteoporosis:

a DXA T-score of −2.5 or less , or a fragility fracture;

treated with calcium and vitamin D , exercise, fall prevention, bisphosphonates (alendronate; take upright with water) or denosumab.

Primary bone tumors are covered in orthopedics.

Dermatology

Describing lesions:

  • flat lesions: a macule (under 1 cm) or patch ;
  • raised solid lesions: a papule (under 1 cm), plaque or nodule ;
  • fluid-filled: a vesicle (under 1 cm) or bulla ; a pustule contains pus;
  • a wheal is transient (urticaria);

secondary changes include scale, crust, erosion, ulcer and lichenification.

Skin infections and infestations:

scabies : intensely itchy papules and burrows in the finger webs , wrists, waist and genitals, worse at night , with household members also itching . Treated with permethrin 5% cream from the neck down (repeat in 1 week), treating all contacts at once and washing bedding; ivermectin for crusted scabies;

impetigo : honey-colored crusts ( S. aureus , S. pyogenes ), treated with topical mupirocin or oral antibiotics. Post-streptococcal GN can follow;

cellulitis and erysipelas : treated with oral or IV antistaphylococcal and antistreptococcal antibiotics;

dermatophytoses (tinea) : annular scaly plaques with central clearing (corporis, cruris, pedis, capitis), diagnosed by KOH and treated with topical azoles or terbinafine. Tinea capitis needs oral griseofulvin or terbinafine. Steroid creams cause tinea incognito ;

pityriasis versicolor ( Malassezia ): hypo- or hyperpigmented scaly macules on the trunk with a "spaghetti and meatballs" KOH pattern, treated with selenium sulfide or azoles;

herpes zoster : a painful dermatomal vesicular rash, treated with acyclovir or valacyclovir within 72 hours . Zoster in a young adult should prompt an HIV test , and eye involvement (Hutchinson sign) needs ophthalmology;

leprosy : hypopigmented anesthetic patches and thickened nerves (see public health).

Eczema and psoriasis:

atopic dermatitis : itchy flexural eczema with a personal or family history of atopy, treated with emollients , topical steroids and calcineurin inhibitors;

contact dermatitis : irritant, or allergic (nickel, cosmetics, plants) with a delayed type IV reaction;

psoriasis : well-demarcated erythematous plaques with silvery scale on the extensor surfaces , scalp and nails (pitting, onycholysis), with the Koebner phenomenon and Auspitz sign . Treated with topical steroids and vitamin D analogs, phototherapy, methotrexate and biologics. Avoid systemic steroids , which can cause a pustular flare on withdrawal. It is linked to metabolic syndrome.

Acne vulgaris: comedones, papules and pustules, treated with topical retinoids and benzoyl peroxide, oral doxycycline, and isotretinoin for severe nodular acne ( teratogenic , so pregnancy prevention is needed).

Severe cutaneous adverse drug reactions:

Stevens-Johnson syndrome (under 10% skin detachment) and toxic epidermal necrolysis (over 30%) : fever and flu-like symptoms, then painful dusky macules, blisters, mucosal erosions and a positive Nikolsky sign , 4 to 28 days after starting the drug;

common culprits: carbamazepine (HLA-B*15:02 in Southeast Asians) , allopurinol (HLA-B*58:01) , sulfonamides , phenytoin, lamotrigine and nevirapine ;

stop the drug immediately , give burn-unit-style supportive care, eye care and fluids; never rechallenge ;

DRESS : rash, fever, eosinophilia , lymphadenopathy and hepatitis 2 to 8 weeks after the drug.

Skin signs of systemic disease:

  • malar rash sparing the nasolabial folds and discoid lesions (SLE);
  • acanthosis nigricans (insulin resistance, sometimes gastric cancer);
  • erythema nodosum : tender shins, from TB, streptococcal infection, sarcoidosis, IBD, pregnancy and drugs;
  • pyoderma gangrenosum (IBD);
  • necrobiosis lipoidica (diabetes);
  • palpable purpura (vasculitis);
  • Janeway lesions and Osler nodes (endocarditis);

xanthomas (hyperlipidemia).